What is Nutromics?
Nutromics is at the forefront of addressing critical healthcare challenges through advanced continuous diagnostic monitoring. The company is developing a pioneering lab-on-a-patch technology that integrates multiple DNA-based sensors with microneedles. This sophisticated system is designed to deliver real-time health data, offering trend insights crucial for clinical decision-making. By providing this continuous stream of information, Nutromics aims to significantly enhance patient outcomes and contribute to the reduction of healthcare expenditures. Their target market includes healthcare providers and institutions actively seeking cutting-edge diagnostic solutions.
How much funding has Nutromics raised?
Nutromics has raised a total of $19.7M across 2 funding rounds:
Unspecified
$5.7M
Other Financing Round
$14M
Unspecified (2021): $5.7M with participation from Artesian Capital Partners
Other Financing Round (2022): $14M led by Artesian Investments, Dexcom Ventures, and VU Venture Partners
Key Investors in Nutromics
VU Venture Partners
VU Venture Partners is a multi-stage global venture capital fund that focuses on investing in Consumer, Enterprise, Fintech, Frontier, Healthcare, and PropTech sectors. With a robust investment team of over 70 professionals, VU has a track record of early investments in more than 25 unicorns and 20 multi-billion exits.
Artesian Capital Partners
Artesian Capital Partners is an integrated company specializing in the engineering, manufacturing, and assembly of customized water and wastewater treatment solutions. They offer large water users an economic and sustainable approach to addressing their water and wastewater challenges.
Dexcom Ventures
Dexcom Ventures is an investment arm focused on advancing healthcare technologies, likely specializing in areas related to continuous monitoring and diabetes management.
What's next for Nutromics?
The recent major strategic investment positions Nutromics for accelerated growth and further development of its groundbreaking lab-on-a-patch technology. This capital infusion is expected to fuel advancements in their diagnostic capabilities, potentially expanding the range of health markers that can be monitored in real-time. With a focus on improving patient care and optimizing healthcare economics, Nutromics is poised to make a significant impact on the diagnostic landscape. Future endeavors will likely involve scaling production, further clinical validation, and broader market penetration, solidifying their role as a key innovator in personalized and continuous health monitoring.
See full Nutromics company page
